| suicide risk |
phenotype |
5 |
3 |
state suicides, suicidality, suicide, suicide rates, suicide risk |
| sum scores |
drug |
4 |
3 |
genetic risk scores, raw sum scores |
| SUNY Downstate Medical Center |
cohort |
2 |
1 |
|
| SuperScript II |
drug |
2 |
1 |
SSII |
| Superscript III reverse transcriptase |
drug |
7 |
1 |
Superscript III |
| surface area |
phenotype |
8 |
4 |
SA, brain surface area, cortical surface area, surface area |
| susceptibility |
phenotype |
3 |
1 |
vulnerability |
| susceptibility genes |
cohort |
4 |
3 |
presumptive susceptibility gene, single susceptibility gene |
| SuSiE |
drug |
2 |
2 |
SUSIE106 |
| sustained attention |
phenotype |
6 |
5 |
performance on sustained attention |
| Sv2a |
gene |
2 |
2 |
synaptic vesicle glycoprotein 2A |
| sweating |
phenotype |
4 |
2 |
|
| Sweden |
cohort |
10 |
4 |
Sweden, Swedish cohort, Swedish population |
| Swedish Twin Registry |
cohort |
5 |
2 |
STR |
| SwissProt |
drug |
2 |
1 |
|
| switch error rate |
phenotype |
2 |
2 |
switch error |
| SWM |
phenotype |
2 |
2 |
spatial working memory |
| SYBR green |
drug |
8 |
2 |
SYBR Green, SYBR Green I, Sybr Green I |
| symptom |
phenotype |
4 |
2 |
item, symptom i |
| symptom count |
phenotype |
9 |
3 |
CIDI-SAM symptom count, SC, symptom count (SC) |
